-
-
-
-
-
-
-
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Sarepta Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q2 EPS by $1.32
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Lowers Guidance
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Reports Preliminary Fourth Quarter and Full-Year 2024 Net Product Revenue
-
-
-
-
-
-
-
Sarepta Therapeutics falls on revenue miss, weak outlook
-
-
-
-
-
-
-
Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
-
1,233,850 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


